rs78430478

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_014251.3(SLC25A13):​c.93T>C​(p.Gly31Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0019 in 1,613,018 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 26 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 20 hom. )

Consequence

SLC25A13
NM_014251.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.117

Publications

0 publications found
Variant links:
Genes affected
SLC25A13 (HGNC:10983): (solute carrier family 25 member 13) This gene is a member of the mitochondrial carrier family. The encoded protein contains four EF-hand Ca(2+) binding motifs in the N-terminal domain, and localizes to mitochondria. The protein catalyzes the exchange of aspartate for glutamate and a proton across the inner mitochondrial membrane, and is stimulated by calcium on the external side of the inner mitochondrial membrane. Mutations in this gene result in citrullinemia, type II. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2009]
SLC25A13 Gene-Disease associations (from GenCC):
  • citrin deficiency
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • citrullinemia, type II, adult-onset
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • citrullinemia type II
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal intrahepatic cholestasis due to citrin deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 7-96277315-A-G is Benign according to our data. Variant chr7-96277315-A-G is described in ClinVar as Benign. ClinVar VariationId is 260372.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.117 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0102 (1546/152246) while in subpopulation AFR AF = 0.0357 (1485/41546). AF 95% confidence interval is 0.0342. There are 26 homozygotes in GnomAd4. There are 754 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 26 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A13NM_014251.3 linkc.93T>C p.Gly31Gly synonymous_variant Exon 3 of 18 ENST00000265631.10 NP_055066.1 Q9UJS0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A13ENST00000265631.10 linkc.93T>C p.Gly31Gly synonymous_variant Exon 3 of 18 1 NM_014251.3 ENSP00000265631.6 Q9UJS0-1
SLC25A13ENST00000416240.6 linkc.93T>C p.Gly31Gly synonymous_variant Exon 3 of 18 1 ENSP00000400101.2 Q9UJS0-2
SLC25A13ENST00000472162.2 linkn.93T>C non_coding_transcript_exon_variant Exon 3 of 5 4 ENSP00000473505.1 R4GN64

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1540
AN:
152128
Hom.:
26
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0357
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00255
AC:
637
AN:
249874
AF XY:
0.00184
show subpopulations
Gnomad AFR exome
AF:
0.0344
Gnomad AMR exome
AF:
0.00200
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000708
Gnomad OTH exome
AF:
0.00181
GnomAD4 exome
AF:
0.00104
AC:
1518
AN:
1460772
Hom.:
20
Cov.:
30
AF XY:
0.000877
AC XY:
637
AN XY:
726636
show subpopulations
African (AFR)
AF:
0.0371
AC:
1241
AN:
33432
American (AMR)
AF:
0.00226
AC:
101
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26058
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39624
South Asian (SAS)
AF:
0.0000929
AC:
8
AN:
86130
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53310
Middle Eastern (MID)
AF:
0.00122
AC:
7
AN:
5748
European-Non Finnish (NFE)
AF:
0.0000279
AC:
31
AN:
1111506
Other (OTH)
AF:
0.00215
AC:
130
AN:
60332
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1546
AN:
152246
Hom.:
26
Cov.:
32
AF XY:
0.0101
AC XY:
754
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0357
AC:
1485
AN:
41546
American (AMR)
AF:
0.00288
AC:
44
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68022
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
72
144
215
287
359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00422
Hom.:
10
Bravo
AF:
0.0114
Asia WGS
AF:
0.00289
AC:
10
AN:
3474
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 28, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Citrin deficiency Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
7.9
DANN
Benign
0.72
PhyloP100
-0.12
Mutation Taster
=292/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs78430478; hg19: chr7-95906627; API